Farms.com Home   Farm Equipment News

John Deere G Series Excavators Increase Comfort And Productivity

John Deere & Company has recently announced the addition of two new models to their G-Series excavators that feature a wide variety of improvements, increasing uptime, comfort, and overall productivity for operators. This is according to a company press release.

According to the release, the John Deere 50G and John Deere 60G excavator models, are particularly well-suited for the rental, commercial/residential building, landscaping, and site development segments. Both new models feature an innovative wider door design for improved entry and visibility to the left hand side of the machine. For increased uptime, Deere added a third service door to each model to provide improved access to the cooling core. The cores are positioned side-by-side versus being stacked in-line for increased performance.

The 50G and 60G also offer a new multifunction monitor which provides a coolant temperature and fuel gauge, clock, two trip meters, regeneration inhibit, auto shut down control, and machine hour display.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.